Cargando…
Application of Patient-Reported Outcome Measurements in Clinical Trials in China
IMPORTANCE: Regulatory authorities, industry peers, and international health policies have emphasized the value of assessing patient-reported outcomes (PROs) in clinical studies. Despite the increase in the number of clinical studies in the last decade in China, little is known about the extent of t...
Autores principales: | Zhou, Hui, Yao, Mi, Gu, Xiaodan, Liu, Mingrui, Zeng, Ruifeng, Li, Qin, Chen, Tingjia, He, Wen, Chen, Xiao, Yuan, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096600/ https://www.ncbi.nlm.nih.gov/pubmed/35544134 http://dx.doi.org/10.1001/jamanetworkopen.2022.11644 |
Ejemplares similares
-
Estimated Cost-effectiveness of Newborn Screening for Congenital Cytomegalovirus Infection in China Using a Markov Model
por: Chen, Kai, et al.
Publicado: (2020) -
Assessment of Hearing Screening Combined With Limited and Expanded Genetic Screening for Newborns in Nantong, China
por: Zhu, Qing-Wen, et al.
Publicado: (2021) -
Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in China
por: Qiao, Han, et al.
Publicado: (2022) -
Association Between Residential Greenness, Cardiometabolic Disorders, and Cardiovascular Disease Among Adults in China
por: Yang, Bo-Yi, et al.
Publicado: (2020) -
Initiating ivabradine during hospitalization in patients with acute heart failure: A real‐world experience in China
por: Liu, Ying‐Xian, et al.
Publicado: (2022)